233 related articles for article (PubMed ID: 8404857)
1. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
Franzoso G; Bours V; Azarenko V; Park S; Tomita-Yamaguchi M; Kanno T; Brown K; Siebenlist U
EMBO J; 1993 Oct; 12(10):3893-901. PubMed ID: 8404857
[TBL] [Abstract][Full Text] [Related]
2. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
Franzoso G; Bours V; Park S; Tomita-Yamaguchi M; Kelly K; Siebenlist U
Nature; 1992 Sep; 359(6393):339-42. PubMed ID: 1406939
[TBL] [Abstract][Full Text] [Related]
3. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.
Nolan GP; Fujita T; Bhatia K; Huppi C; Liou HC; Scott ML; Baltimore D
Mol Cell Biol; 1993 Jun; 13(6):3557-66. PubMed ID: 8497270
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.
Caamaño JH; Perez P; Lira SA; Bravo R
Mol Cell Biol; 1996 Apr; 16(4):1342-8. PubMed ID: 8657107
[TBL] [Abstract][Full Text] [Related]
5. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
[TBL] [Abstract][Full Text] [Related]
6. Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.
Watanabe N; Iwamura T; Shinoda T; Fujita T
EMBO J; 1997 Jun; 16(12):3609-20. PubMed ID: 9218802
[TBL] [Abstract][Full Text] [Related]
7. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers.
Fujita T; Nolan GP; Liou HC; Scott ML; Baltimore D
Genes Dev; 1993 Jul; 7(7B):1354-63. PubMed ID: 8330739
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family.
Pan J; McEver RP
J Biol Chem; 1995 Sep; 270(39):23077-83. PubMed ID: 7559449
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene.
Kurland JF; Kodym R; Story MD; Spurgers KB; McDonnell TJ; Meyn RE
J Biol Chem; 2001 Nov; 276(48):45380-6. PubMed ID: 11567031
[TBL] [Abstract][Full Text] [Related]
10. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
11. Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins.
Inoue J; Takahara T; Akizawa T; Hino O
Oncogene; 1993 Aug; 8(8):2067-73. PubMed ID: 8336935
[TBL] [Abstract][Full Text] [Related]
12. The MEK/ERK pathway acts upstream of NF kappa B1 (p50) homodimer activity and Bcl-2 expression in a murine B-cell lymphoma cell line. MEK inhibition restores radiation-induced apoptosis.
Kurland JF; Voehringer DW; Meyn RE
J Biol Chem; 2003 Aug; 278(34):32465-70. PubMed ID: 12801933
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
Matthews JR; Watson E; Buckley S; Hay RT
Nucleic Acids Res; 1993 Sep; 21(19):4516-23. PubMed ID: 7694229
[TBL] [Abstract][Full Text] [Related]
14. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.
Jiang HY; Petrovas C; Sonenshein GE
J Virol; 2002 Jun; 76(11):5737-47. PubMed ID: 11992002
[TBL] [Abstract][Full Text] [Related]
15. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
16. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation.
Kunsch C; Ruben SM; Rosen CA
Mol Cell Biol; 1992 Oct; 12(10):4412-21. PubMed ID: 1406630
[TBL] [Abstract][Full Text] [Related]
17. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.
Bours V; Franzoso G; Azarenko V; Park S; Kanno T; Brown K; Siebenlist U
Cell; 1993 Mar; 72(5):729-39. PubMed ID: 8453667
[TBL] [Abstract][Full Text] [Related]
18. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages.
Wessells J; Baer M; Young HA; Claudio E; Brown K; Siebenlist U; Johnson PF
J Biol Chem; 2004 Nov; 279(48):49995-50003. PubMed ID: 15465827
[TBL] [Abstract][Full Text] [Related]
19. Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.
Collins PE; Grassia G; Colleran A; Kiely PA; Ialenti A; Maffia P; Carmody RJ
J Biol Chem; 2015 Jun; 290(25):15687-15696. PubMed ID: 25922067
[TBL] [Abstract][Full Text] [Related]
20. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
